GH Research - private company seeking to patent a ROA

[moonbeam]

I was surprised to come across this private company doing a clinical study on the use of 5-MeO-DMT for treating treatment-resistant depression.  It looks like they’re seeking to patent a certain Route of Administration.  No mention of it being an adjunct to psychotherapy.

https://www.ghres.com/pipeline


GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress